Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

9.970 -0.800 (-7.43%)
Streaming Delayed Price Updated: 11:40 AM EST, Nov 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 425,391
Open 10.84
Bid (Size) 9.900 (2,000)
Ask (Size) 9.970 (800)
Prev. Close 10.77
Today's Range 9.580 - 10.84
52wk Range 2.380 - 12.23
Shares Outstanding 16,126,784
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Exagen Inc. (NASDAQ:XGN) Reports Mixed Q3 2025 Results with Revenue Beat and Wider-Than-Expected Loss
Exagen's Q3 2025 results show a revenue beat but a wider-than-expected loss, causing a pre-market stock decline. 
Via Chartmill
Exagen Inc. Reports Strong Q3 2025 Results
From Exagen Inc.
Via GlobeNewswire

Performance

YTD
+222.7%
+222.7%
1 Month
-8.5%
-8.5%
3 Month
+12.4%
+12.4%
6 Month
+55.3%
+55.3%
1 Year
+303.6%
+303.6%

More News

Read More
Earnings Scheduled For November 4, 2025
Via Benzinga
Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
From Exagen Inc.
Via GlobeNewswire
Beyond The Numbers: 4 Analysts Discuss Exagen Stock
Via Benzinga
What Analysts Are Saying About Exagen Stock
Via Benzinga
Demystifying Exagen: Insights From 5 Analyst Reviews
Via Benzinga
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Participate in Third Quarter Investor Conferences
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Earnings Scheduled For July 29, 2025
Via Benzinga
Exagen Q2 Revenue Jumps 14 Percent
Via The Motley Fool
Topics Intellectual Property
Exagen Inc (NASDAQ:XGN) Surpasses Revenue Estimates in Q2 2025 Despite Wider Loss, Shares Rally in Pre-Market Trading
Via Chartmill
Exagen Inc. Reports Strong Q2 2025 Results
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Appoints Chas McKhann to Board of Directors
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. to Announce Second Quarter 2025 Financial Results on July 29, 2025
From Exagen Inc.
Via GlobeNewswire
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
From Exagen Inc.
Via GlobeNewswire
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares
From Exagen Inc.
Via GlobeNewswire
Top movers in Thursday's pre-market session
Via Chartmill
Exagen Inc. Prices Public Offering of Common Stock
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Exagen Inc. Announces Proposed Public Offering of Common Stock
From Exagen Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Exagen Inc. - Common Stock publicly traded?
Yes, Exagen Inc. - Common Stock is publicly traded.
What exchange does Exagen Inc. - Common Stock trade on?
Exagen Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Exagen Inc. - Common Stock?
The ticker symbol for Exagen Inc. - Common Stock is XGN on the Nasdaq Stock Market
What is the current price of Exagen Inc. - Common Stock?
The current price of Exagen Inc. - Common Stock is 9.970
When was Exagen Inc. - Common Stock last traded?
The last trade of Exagen Inc. - Common Stock was at 11/05/25 11:40 AM ET
What is the market capitalization of Exagen Inc. - Common Stock?
The market capitalization of Exagen Inc. - Common Stock is 160.78M
How many shares of Exagen Inc. - Common Stock are outstanding?
Exagen Inc. - Common Stock has 161M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.